Technology
Health
Pharmaceutical

Theravance Biopharma

$18.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.94 (-4.90%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell TBPH and other stocks, options, ETFs, and crypto commission-free!

About

Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of small molecule medicines. Read More Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Employees
363
Headquarters
George Town, George Town
Founded
2013
Market Cap
1.02B
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
230.80K
High Today
$18.95
Low Today
$17.87
Open Price
$18.95
Volume
181.37K
52 Week High
$35.48
52 Week Low
$17.87

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
2014 IPO
North America (Non-US/Canada)
North America

News

NasdaqMay 8

Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates

13
Seeking AlphaMay 7

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2019 Results - Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2019 Earnings Conference Call May 7, 2019 5:00 PM ET Company Participants Jessica Stitt - Vice President, Finance & Investor Relations Rick Winningham - Chief Executive Officer Brett Haumann - Chief Medical Officer Frank Pasqualone - Senior Vice President & Chief Commercial Operations Officer Conference Call Participants Brad Canino - SVB Leerink Louise Chen - Cantor Fitzgerald Alex Duncan - Piper Jaffray Brian Skorney - Baird Alan Carr - Needham Opera...

36
PR NewswireMay 7

Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

9

Earnings

-$1.64
-$1.35
-$1.05
-$0.76
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.